Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.9K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.9K
Standard Precaution01:26

Standard Precaution

3.2K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
3.2K
Ethical Standards II01:23

Ethical Standards II

1.2K
Ethical standards are the backbone of nursing practice, guiding nurses as they interact with patients, families, and colleagues. These standards are crucial for providing safe, empathetic care centered on the patient's needs.
Nurses are entrusted with upholding various ethical principles and standards. Nurses forge solid therapeutic relationships using trust, empathy, autonomy, confidentiality, and professional competence.
Confidentiality is crucial, embodying respect for individual privacy...
1.2K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

2.0K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K
Types of Reports II: Incident or Occurrence Report01:21

Types of Reports II: Incident or Occurrence Report

1.3K
An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
1.3K
PPE Use in Healthcare Settings II: Doffing01:10

PPE Use in Healthcare Settings II: Doffing

1.6K
The sequence of removing or doffing PPE starts with the gloves, as they are the most contaminated. Next is removal of the face shield or goggles, as they would interfere with removing other PPE. Then remove the gown, followed by the mask or respirator. Perform hand hygiene between steps if hands become contaminated and immediately after removing all PPE. Generally, the outside front and sleeves of the isolation gown, the goggles or the mask, the respirator, and the face shield are contaminated.
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uncovering gaps in HIV care in belgium through patient reported outcome measures and neurocognitive screening.

Discover mental health·2026
Same author

Epidemiology of influenza over a ten-year period in Belgium: overview of the historical and current evidence.

Virology journal·2023
Same author

An unusual case of a gallbladder polyp.

Acta gastro-enterologica Belgica·2021
Same author

Diagnostic approach for detection and identification of emerging enteric pathogens revisited: the <i>(Ali)arcobacter lanthieri</i> case.

New microbes and new infections·2021
Same author

[Recurrence of dengue epidemics in Burkina Faso: Community preference for an intervention to prevent the disease].

Revue d'epidemiologie et de sante publique·2019
Same author

A hospital wide predictive model for unplanned readmission using hierarchical ICD data.

Computer methods and programs in biomedicine·2019

Related Experiment Video

Updated: Apr 29, 2026

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
11:14

Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

Published on: October 12, 2018

8.2K

HIV disclosure in the workplace.

S Degroote, D Vogelaers, R Koeck

    Acta Clinica Belgica
    |May 14, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Many people living with HIV (PLHIV) fear workplace discrimination, leading them to not disclose their status. However, HIV medication adherence at work is generally not an issue for those who do disclose.

    Keywords:
    Disclosure,HIV,Work

    More Related Videos

    Humanized NOD/SCID/IL2r&#947;null (hu-NSG) Mouse Model for HIV Replication and Latency Studies
    07:10

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

    Published on: January 7, 2019

    14.1K
    Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
    08:15

    Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

    Published on: January 31, 2020

    7.5K

    Related Experiment Videos

    Last Updated: Apr 29, 2026

    Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
    11:14

    Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture

    Published on: October 12, 2018

    8.2K
    Humanized NOD/SCID/IL2r&#947;null (hu-NSG) Mouse Model for HIV Replication and Latency Studies
    07:10

    Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

    Published on: January 7, 2019

    14.1K
    Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection
    08:15

    Humanized NOG Mice for Intravaginal HIV Exposure and Treatment of HIV Infection

    Published on: January 31, 2020

    7.5K

    Area of Science:

    • Occupational Health
    • Public Health
    • Social Sciences

    Background:

    • HIV is now a manageable chronic condition.
    • More people living with HIV (PLHIV) are re-entering the workforce.
    • Limited research exists on PLHIV workplace experiences.

    Purpose of the Study:

    • To explore workplace experiences of PLHIV.
    • To investigate HIV status disclosure in the workplace.
    • To assess antiretroviral therapy (ART) adherence among PLHIV at work.

    Main Methods:

    • A validated questionnaire was developed with Sensoa.
    • Participants were recruited via flyers and online announcements.
    • 54 PLHIV completed the survey.

    Main Results:

    • Half of participants (50/54 males) did not disclose their HIV status due to fear of consequences.
    • Those who disclosed reported no negative changes, some even experienced more empathy.
    • A minority taking ART at work reported no significant issues with medication intake.

    Conclusions:

    • Fear of discrimination prevents many PLHIV from disclosing their status at work.
    • Further interventions are needed to address disclosure barriers and self-stigma.
    • Workplace ART adherence is generally unproblematic for PLHIV.